Catalyst Wire Dossier Catalyst Wire Dossier

Sodium hyaluronate ophthalmic solution

sodium hyaluronate · SIFI SpA
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sodium hyaluronate ophthalmic solution, covering 2026-01-07 to 2026-01-07. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Investigation on the Use of Ophthalmic Solution Based on Sodium Hyaluronate in Treatment of Eye Discomfort

See pricing